should glp-1 agonists be open access Mapping the effectiveness and risks of receptor Is biased agonism helpful in

A growing body of work suggests GLP-1 drugs act on platelets, immune cells, and vascular cells to protect against atherosclerosis independently of their effects on glycemia, appetite, and weight

Glucagon-like peptide-1 receptor agonists as a disease-modifying therapy for knee osteoarthritis mediated by weight loss: findings from the Shanghai osteoarthritis cohort

260 GLP-1 downregulated Na+/H+ exchanger isoform 3 in the renal proximal tubule of rats, suggesting that GLP-1 could be used to treat hypertension and sodium retention disorders

C.et al (2015)

Lifestyle factors can either support or blunt the bodys natural appetite-regulating signals

Predictive model of IVF outcomes for polycystic ovarian morphology and polycystic ovary syndrome in GnRH antagonist protocol using AMH-MoM and ovarian sensitivity index